Our Successes

Below are some of the top whistleblower cases, in which we have successfully represented clients. We measure our success not only by the billions of stolen dollars that we have helped the government recover for taxpayers over the past twenty years – including through the largest False Claims Act case settlements in both 2017 and 2018 and the largest intervened FCA recovery in 2022 – but also by our track record in protecting public health and safety, bringing criminal wrongdoers to justice, preventing further fraud, and standing up for our clients who had the courage to bring illegal practices to light.

AmerisourceBergen Corp.
$885 million
Amgen Inc.
$762 million
Serono
$704 million
Mylan Inc.
$465 million
Mallinckrodt
$234 million

Our Successes

BioTel and LifeWatch – $13 million

The United States settled a False Claims Act case brought by one of our clients against BioTel and LifeWatch, two...
Read More >>

Massachusetts Eye and Ear (MEEI) – $5.7 Million

In May 2023, the United States settled a False Claims Act case that our client brought against Massachusetts Eye and...
Read More >>

ZOLL Medical Corporation – $400,000

ZOLL Medical Corporation, headquartered in Massachusetts with locations in Rhode Island, will pay the United States $400,000 to resolve allegations...
Read More >>

Oncology Physician Practice – $1 Million

An oncology physician practice who did business with Cardinal Health paid the United States and the State of Michigan agreed...
Read More >>

DermaTran Health – $6.87 Million

In October, 2022, the United States settled a False Claims Act case brought one of our clients against DermaTran Health Solutions, LLC,...
Read More >>

SEC Whistleblower Program: $17 Million To Our Anonymous Client

The Securities and Exchange Commission (SEC) awarded more than $17 million to a whistleblower represented by Whistleblower Law Collaborative’s Suzanne...
Read More >>

BioReference – $10 Million

In July 2022, the United States, Massachusetts, and Connecticut settled a False Claims Act case that our client brought against...
Read More >>

Mallinckrodt – $234 Million

This settlement among the United States, the States, and pharmaceutical companies Mallinckrodt plc and its subsidiary Mallinckrodt ARD LLC resolved...
Read More >>

Cardinal Health – $13.125 Million

Cardinal Health has agreed to pay the United States and the states $ 13.125 million plus interest to resolve allegations...
Read More >>